vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and HARTE HANKS INC (HHS). Click either name above to swap in a different company.

HARTE HANKS INC is the larger business by last-quarter revenue ($39.9M vs $23.1M, roughly 1.7× ADC Therapeutics SA). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -15.4%). Over the past eight quarters, ADC Therapeutics SA's revenue compounded faster (13.7% CAGR vs -6.4%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

ADCT vs HHS — Head-to-Head

Bigger by revenue
HHS
HHS
1.7× larger
HHS
$39.9M
$23.1M
ADCT
Growing faster (revenue YoY)
ADCT
ADCT
+51.8% gap
ADCT
36.4%
-15.4%
HHS
Faster 2-yr revenue CAGR
ADCT
ADCT
Annualised
ADCT
13.7%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ADCT
ADCT
HHS
HHS
Revenue
$23.1M
$39.9M
Net Profit
$2.2M
Gross Margin
Operating Margin
-77.7%
-0.3%
Net Margin
5.5%
Revenue YoY
36.4%
-15.4%
Net Profit YoY
EPS (diluted)
$0.04
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
HHS
HHS
Q4 25
$23.1M
$39.9M
Q3 25
$15.8M
$39.5M
Q2 25
$18.1M
$38.6M
Q1 25
$17.4M
$41.6M
Q4 24
$16.9M
$47.1M
Q3 24
$18.0M
$47.6M
Q2 24
$17.0M
$45.0M
Q1 24
$17.8M
$45.4M
Net Profit
ADCT
ADCT
HHS
HHS
Q4 25
$2.2M
Q3 25
$-41.0M
$-2.3M
Q2 25
$-56.6M
$-335.0K
Q1 25
$-38.6M
$-392.0K
Q4 24
Q3 24
$-44.0M
$142.0K
Q2 24
$-36.5M
$-27.8M
Q1 24
$-46.6M
$-171.0K
Operating Margin
ADCT
ADCT
HHS
HHS
Q4 25
-77.7%
-0.3%
Q3 25
-196.6%
1.3%
Q2 25
-244.1%
0.1%
Q1 25
-163.5%
-0.1%
Q4 24
-191.8%
-3.3%
Q3 24
-197.4%
4.0%
Q2 24
-170.5%
3.0%
Q1 24
-188.3%
0.8%
Net Margin
ADCT
ADCT
HHS
HHS
Q4 25
5.5%
Q3 25
-260.1%
-5.8%
Q2 25
-313.2%
-0.9%
Q1 25
-221.8%
-0.9%
Q4 24
Q3 24
-244.1%
0.3%
Q2 24
-214.6%
-61.8%
Q1 24
-261.1%
-0.4%
EPS (diluted)
ADCT
ADCT
HHS
HHS
Q4 25
$0.04
$0.30
Q3 25
$-0.30
$-0.31
Q2 25
$-0.50
$-0.05
Q1 25
$-0.36
$-0.05
Q4 24
$-0.26
$-0.31
Q3 24
$-0.42
$0.02
Q2 24
$-0.38
$-3.84
Q1 24
$-0.56
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
HHS
HHS
Cash + ST InvestmentsLiquidity on hand
$261.3M
$5.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$20.5M
Total Assets
$323.1M
$91.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
HHS
HHS
Q4 25
$261.3M
$5.6M
Q3 25
$234.7M
$6.5M
Q2 25
$264.6M
$4.8M
Q1 25
$194.7M
$9.0M
Q4 24
$250.9M
$9.8M
Q3 24
$274.3M
$5.9M
Q2 24
$300.1M
$11.0M
Q1 24
$234.3M
$11.5M
Stockholders' Equity
ADCT
ADCT
HHS
HHS
Q4 25
$-185.8M
$20.5M
Q3 25
$-238.2M
$19.9M
Q2 25
$-199.2M
$22.2M
Q1 25
$-238.2M
$21.4M
Q4 24
$-202.6M
$21.7M
Q3 24
$-171.9M
$21.0M
Q2 24
$-131.7M
$20.6M
Q1 24
$-194.4M
$20.0M
Total Assets
ADCT
ADCT
HHS
HHS
Q4 25
$323.1M
$91.8M
Q3 25
$289.8M
$92.7M
Q2 25
$321.6M
$95.0M
Q1 25
$272.5M
$100.6M
Q4 24
$322.0M
$101.8M
Q3 24
$349.1M
$108.1M
Q2 24
$371.8M
$109.7M
Q1 24
$308.0M
$113.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
HHS
HHS
Operating Cash FlowLast quarter
$-31.1M
$737.0K
Free Cash FlowOCF − Capex
$-686.0K
FCF MarginFCF / Revenue
-1.7%
Capex IntensityCapex / Revenue
0.0%
3.6%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
HHS
HHS
Q4 25
$-31.1M
$737.0K
Q3 25
$-29.6M
$3.2M
Q2 25
$-24.1M
$-4.8M
Q1 25
$-56.3M
$-818.0K
Q4 24
$-21.9M
$4.0M
Q3 24
$-25.0M
$-2.9M
Q2 24
$-32.8M
$1.6M
Q1 24
$-44.1M
$-5.7M
Free Cash Flow
ADCT
ADCT
HHS
HHS
Q4 25
$-686.0K
Q3 25
$2.2M
Q2 25
$-5.1M
Q1 25
$-56.6M
$-923.0K
Q4 24
$-21.9M
$3.4M
Q3 24
$-25.3M
$-4.9M
Q2 24
$-32.9M
$926.0K
Q1 24
$-44.6M
$-6.2M
FCF Margin
ADCT
ADCT
HHS
HHS
Q4 25
-1.7%
Q3 25
5.5%
Q2 25
-13.1%
Q1 25
-325.2%
-2.2%
Q4 24
-129.8%
7.3%
Q3 24
-140.2%
-10.2%
Q2 24
-193.0%
2.1%
Q1 24
-250.0%
-13.7%
Capex Intensity
ADCT
ADCT
HHS
HHS
Q4 25
0.0%
3.6%
Q3 25
0.0%
2.5%
Q2 25
0.0%
0.6%
Q1 25
1.5%
0.3%
Q4 24
0.5%
1.3%
Q3 24
1.2%
4.0%
Q2 24
0.2%
1.5%
Q1 24
3.0%
1.2%
Cash Conversion
ADCT
ADCT
HHS
HHS
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-20.76×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADCT
ADCT

Segment breakdown not available.

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

Related Comparisons